Raleigh Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Buy
30,084
+16,556
+122% +$1.34M 0.75% 37
2026
Q1
$1.17M Buy
13,528
+10,198
+306% +$977K 0.4% 70
2025
Q4
$320K Sell
3,330
-18
-0.5% -$1.75K 0.12% 165
2025
Q3
$319K Sell
3,348
-279
-8% -$25.6K 0.12% 158
2025
Q2
$316K Sell
3,627
-221
-6% -$18.7K 0.13% 166
2025
Q1
$346K Sell
3,848
-280
-7% -$25.1K 0.16% 146
2024
Q4
$330K Sell
4,128
-64
-2% -$5.54K 0.13% 160
2024
Q3
$377K Sell
4,192
-674
-14% -$56.7K 0.15% 150
2024
Q2
$383K Buy
4,866
+272
+6% +$22.3K 0.16% 136
2024
Q1
$400K Sell
4,594
-13,864
-75% -$1.18M 0.17% 138
2023
Q4
$1.52M Sell
18,458
-678
-4% -$51.7K 0.71% 43
2023
Q3
$1.5M Buy
19,136
+2,161
+13% +$181K 0.76% 42
2023
Q2
$1.5M Sell
16,975
-1,370
-7% -$118K 0.75% 44
2023
Q1
$1.48M Buy
18,345
+758
+4% +$61.8K 0.73% 43
2022
Q4
$1.37M Buy
17,587
+12,644
+256% +$1.02M 0.71% 43
2022
Q3
$399K Buy
4,943
+357
+8% +$32.1K 0.23% 114
2022
Q2
$412K Buy
4,586
+242
+6% +$24.5K 0.23% 109
2022
Q1
$482K Buy
4,344
+1,103
+34% +$117K 0.26% 106
2021
Q4
$335K Buy
+3,241
New +$375K 0.34% 71

Other funds holding MDT

Raleigh Capital Management's MDT Position: Q2 2026 in Review

Raleigh Capital Management increased its Medtronic (MDT) stake by 122% in Q2 2026, buying an estimated $1.34M and bringing the position to 30,084 shares worth $2.35M. The position accounts for 0.75% of the portfolio, ranked #37.

Raleigh Capital Management first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. 534 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Raleigh Capital Management held 30,084 shares of Medtronic worth $2.35M as of Q2 2026.
  • Raleigh Capital Management bought 16,556 Medtronic shares in Q2 2026, an estimated $1.34M.
  • Medtronic made up 0.75% of Raleigh Capital Management's portfolio in Q2 2026, its #37 holding.
  • Raleigh Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • 534 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.